Literature DB >> 9610514

[Löffler fibroblastic endocarditis in the thrombotic stages in isolated right ventricular tissue eosinophilia].

A Hagendorff1, M Hümmelgen, H Omran, L Pizzulli, M Zirbes, E Bierhoff, T Sommer, U Pfeifer, P G Kirchhoff, J Nitsch, B Lüderitz.   

Abstract

We report on a male, 31 year old, Turkish patient with an intracardiac mass in the right ventricle, reduction of performance and weight, as well as intermittent fever. No eosinophilia was documented in the peripheral blood; cardiac function was primarily normal. Besides the differential diagnosis of Löffer's endocarditis (endomyocardial fibrosis) an inflammatory disease and a malignant cardiac tumor were suggested. The diagnosis of Löffler's endocarditis could not be confirmed morphologically by echocardiography nor histologically by right ventricular biopsy. Operative removal of the mass lesion was necessary because of fast tumor progression, fulminant pulmonary embolism, and infiltration of the tricuspid valve. Only then, histologically Löffler's eosinophilic endocarditis of thrombotic stage was diagnosed. Antiphlogistic therapy with cortisone was initially performed. With a dose reduction after 6 months, a relapse of the thrombotic mass occurred. Therefore, continuous treatment with cortisone and azathioprine was induced followed by further tumor regression and further clinical stabilization since 8 months of treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610514     DOI: 10.1007/s003920050183

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  2 in total

1.  Löffler endocarditis without peripheral eosinophilia.

Authors:  G H Wasmeier; D Ropers; A Dimmler; T Fischlein; W G Daniel
Journal:  Clin Res Cardiol       Date:  2007-01-22       Impact factor: 5.460

2.  Large apical thrombus in a patient with persistent heart failure and hypereosinophilia: Löffler endocarditis.

Authors:  A Altug Cincin; Beste Ozben; M Azra Tanrikulu; Ozdil Baskan; Mehmet Agirbasli
Journal:  J Gen Intern Med       Date:  2008-07-10       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.